THERMO FISHER SCIENTIFIC

(TMO)
  Report
Real-time Estimate Cboe BZX  -  05/17 03:04:25 pm EDT
555.25 USD   +2.94%
05/11TRANSCRIPT : Thermo Fisher Scientific Inc. Presents at Bank of America 2022 Healthcare Conference, May-11-2022 09:20 AM
CI
05/11IonPath, Inc. announced that it has received funding from Thermo Fisher Scientific Inc.
CI
05/10Thermo Fisher Scientific Introduces QualTrak Biopharma qPCR Solutions to Streamline Biologics Development and Compliance
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Thermo Fisher Scientific Exec Says Pricing Is Going To Be Higher In 2022 Than In Past Years- JPM Conf

01/11/2022 | 08:54am EDT

Jan 11 (Reuters) - Thermo Fisher Scientific Inc:

* THERMO FISHER SCIENTIFIC EXEC SAYS DEMAND FOR VACCINES WILL BE RELEVANT AT LEAST INTO 2023, HARDER TO TELL BEYOND THAT- JPM CONF

* THERMO FISHER SCIENTIFIC EXEC SAYS PRICING IS GOING TO BE HIGHER IN 2022 THAN IN PAST YEARS- JPM CONF Further company coverage:


ę Reuters 2022
All news about THERMO FISHER SCIENTIFIC
05/11TRANSCRIPT : Thermo Fisher Scientific Inc. Presents at Bank of America 2022 Healthcare Con..
CI
05/11IonPath, Inc. announced that it has received funding from Thermo Fisher Scientific Inc.
CI
05/10Thermo Fisher Scientific Introduces QualTrak Biopharma qPCR Solutions to Streamline Bio..
CI
05/06THERMO FISHER SCIENTIFIC INC. Management's Discussion and Analysis of Financial Condit..
AQ
05/06Thermo Fisher Scientific to Present at BofA Securities 2022 Healthcare Conference
BU
05/06INSIDER SELL : Thermo Fisher Scientific
MT
05/05Interim report 1 January – 31 March 2022
AQ
05/04Thermo Fisher Scientific Inc. Launches Thermo Scientificdionex CR-CTC III Application W..
CI
04/29Morgan Stanley Adjusts Thermo Fisher Scientific's Price Target to $670 from $700, Keeps..
MT
04/28SECTOR UPDATE : Health Care Stocks Carried Higher in Thursday Markets Recovery
MT
More news
Analyst Recommendations on THERMO FISHER SCIENTIFIC
More recommendations
Financials (USD)
Sales 2022 42 581 M - -
Net income 2022 6 865 M - -
Net Debt 2022 25 677 M - -
P/E ratio 2022 31,2x
Yield 2022 0,22%
Capitalization 211 B 211 B -
EV / Sales 2022 5,56x
EV / Sales 2023 5,27x
Nbr of Employees 130 000
Free-Float 88,9%
Chart THERMO FISHER SCIENTIFIC
Duration : Period :
Thermo Fisher Scientific Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends THERMO FISHER SCIENTIFIC
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 23
Last Close Price 539,38 $
Average target price 669,21 $
Spread / Average Target 24,1%
EPS Revisions
Managers and Directors
Marc N. Casper Chairman, President & Chief Executive Officer
Stephen Williamson Chief Financial Officer & Senior Vice President
Ryan Snyder Chief Information Officer & Senior Vice President
Alan B. Sachs Chief Medical Officer
Karen E. Nelson Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
THERMO FISHER SCIENTIFIC-18.86%211 147
DANAHER CORPORATION-25.12%176 375
INTUITIVE SURGICAL, INC.-38.90%78 802
SIEMENS HEALTHINEERS AG-15.74%64 712
EDWARDS LIFESCIENCES CORPORATION-25.95%59 645
BOSTON SCIENTIFIC CORPORATION-6.26%56 926